Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosemary Gale

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
British Journal of Haematology|July 21, 2005
Rapid and sensitive detection of internal tandem duplication and activating loop mutations of FLT3Ken I Mills, Amanda F Gilkes, Val Walsh, et al.
British Journal of Haematology|October 9, 2003
Endothelial cells express normal cellular prion proteinRichard Starke, Paul Harrison, Rosemary Gale, et al.
British Journal of Haematology|November 20, 2002
The expression of prion protein by endothelial cells: a source of the plasma form of prion protein?Richard Starke, Olive Drummond, Ian MacGregor, et al.
Leukemia|June 29, 2021
Prognostic value of Oncogenetic mutations in pediatric T Acute Lymphoblastic Leukemia: a comparison of UKALL2003 and FRALLE2000T protocolsMary M Taj, Anthony V Moorman, Lina Hamadeh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2008
Mutation of the Wilms' tumor 1 gene is a poor prognostic factor associated with chemotherapy resistance in normal karyotype acute myeloid leukemia: the United Kingdom Medical Research Council Adult Leukaemia Working PartyPriya Virappane, Rosemary Gale, Robert Hills, et al.
Leukemia|March 21, 2018
The subclonal complexity of STIL-TAL1+ T-cell acute lymphoblastic leukaemiaCaroline L Furness, Marcela B Mansur, Victoria J Weston, et al.
Blood|October 21, 2016
KIR gene haplotype: an independent predictor of clinical outcome in MDS patientsKate Stringaris, David Marin, A John Barrett, et al.
Blood|May 1, 2024
Molecular, clinical, and therapeutic determinants of outcome in NPM1-mutated AMLJad Othman, Nicola Potter, Adam Ivey, et al.
The Journal of Experimental Medicine|July 6, 2016
Genetically distinct leukemic stem cells in human CD34- acute myeloid leukemia are arrested at a hemopoietic precursor-like stageLynn Quek, Georg W Otto, Catherine Garnett, et al.
Blood|January 15, 2020
Molecular MRD status and outcome after transplantation in NPM1-mutated AMLRichard Dillon, Robert Hills, Sylvie Freeman, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
British Journal of Haematology|July 21, 2005
Rapid and sensitive detection of internal tandem duplication and activating loop mutations of FLT3Ken I Mills, Amanda F Gilkes, Val Walsh, et al.
British Journal of Haematology|October 9, 2003
Endothelial cells express normal cellular prion proteinRichard Starke, Paul Harrison, Rosemary Gale, et al.
British Journal of Haematology|November 20, 2002
The expression of prion protein by endothelial cells: a source of the plasma form of prion protein?Richard Starke, Olive Drummond, Ian MacGregor, et al.
Leukemia|June 29, 2021
Prognostic value of Oncogenetic mutations in pediatric T Acute Lymphoblastic Leukemia: a comparison of UKALL2003 and FRALLE2000T protocolsMary M Taj, Anthony V Moorman, Lina Hamadeh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2008
Mutation of the Wilms' tumor 1 gene is a poor prognostic factor associated with chemotherapy resistance in normal karyotype acute myeloid leukemia: the United Kingdom Medical Research Council Adult Leukaemia Working PartyPriya Virappane, Rosemary Gale, Robert Hills, et al.
Leukemia|March 21, 2018
The subclonal complexity of STIL-TAL1+ T-cell acute lymphoblastic leukaemiaCaroline L Furness, Marcela B Mansur, Victoria J Weston, et al.
Blood|October 21, 2016
KIR gene haplotype: an independent predictor of clinical outcome in MDS patientsKate Stringaris, David Marin, A John Barrett, et al.
Blood|May 1, 2024
Molecular, clinical, and therapeutic determinants of outcome in NPM1-mutated AMLJad Othman, Nicola Potter, Adam Ivey, et al.
The Journal of Experimental Medicine|July 6, 2016
Genetically distinct leukemic stem cells in human CD34- acute myeloid leukemia are arrested at a hemopoietic precursor-like stageLynn Quek, Georg W Otto, Catherine Garnett, et al.
Blood|January 15, 2020
Molecular MRD status and outcome after transplantation in NPM1-mutated AMLRichard Dillon, Robert Hills, Sylvie Freeman, et al.
Pageof 2